Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2011 | 09-2011 | 03-2011 | 03-2010 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,485,710 | 3,206,300 | 10,514,570 | 9,166,450 | N/A |
| Marketable Securities | 2,473,520 | 2,030,360 | 18,160 | 330,490 | N/A |
| Receivables | 4,812,930 | -39,950 | 3,381,620 | 2,821,020 | N/A |
| Inventories | 2,702,840 | 1,654,990 | 1,652,130 | 1,480,610 | N/A |
| Other current assets | 3,532,880 | 9,589,330 | 3,544,990 | 3,114,050 | 0 |
| TOTAL | $16,007,880 | $16,441,030 | $19,111,470 | $16,912,620 | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 2,072,600 | 2,091,090 | 1,988,180 | 2,127,370 | 0 |
| Other Non-Current Assets | 19,721,650 | 20,487,670 | 7,325,991 | 7,670,920 | 0 |
| TOTAL | $21,794,250 | $22,578,760 | $9,314,171 | $9,798,290 | $N/A |
| Total Assets | $44,135,840 | $45,140,750 | $33,571,100 | $30,357,780 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 26,950 | 37,320 | N/A |
| Accounts payable and accrued liabilities | 1,263,700 | 0 | 967,710 | 750,800 | 0 |
| Accrued Expenses | 374,460 | N/A | 2,011,940 | 1,765,910 | N/A |
| Other current liabilities | 3,771,440 | 3,802,130 | 1,725,060 | 1,499,240 | N/A |
| TOTAL | $13,248,620 | $13,121,890 | $5,260,190 | $4,607,270 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 197,430 | 166,870 | N/A |
| Other Non-Current Liabilities | 1,839,290 | 1,854,580 | 1,017,680 | 782,800 | 0 |
| TOTAL | $5,411,240 | $5,637,680 | $2,568,060 | $2,473,650 | $N/A |
| Total Liabilities | $18,659,870 | $18,759,570 | $7,828,260 | $7,080,940 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 819,670 | 819,670 | 765,550 | 683,230 | N/A |
| Retained earnings | 29,547,680 | 30,142,510 | 27,374,300 | 23,293,580 | N/A |
| Other shareholders' equity | -5,521,710 | -5,210,340 | -2,983,050 | -1,222,720 | 0 |
| TOTAL | $25,475,970 | $26,381,170 | $25,742,840 | $23,276,830 | $N/A |
| Total Liabilities And Equity | $44,135,840 | $45,140,740 | $33,571,100 | $30,357,770 | $0 |